Every material Form 8-K Protolabs filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Proto Labs reported record third quarter 2025 revenue of $135.4 million, up 7.8% from a year earlier, while GAAP and non-GAAP earnings per share were flat at $0.30 and $0.47. The company guided fourth quarter 2025 revenue to $125.0 million to $133.0 million, below the third quarter level, with non-GAAP diluted EPS of $0.30 to $0.38.
Q3 2025 revenue $135.4 million, up 7.8% from $125.6 million; CNC Machining revenue rose to $63.0 million from $53.3 million
GAAP diluted EPS $0.30 vs $0.29 a year earlier; non-GAAP diluted EPS $0.47, unchanged
Adjusted EBITDA $21.1 million (15.6% margin) vs $21.9 million (17.4% margin) in Q3 2024
Q4 2025 outlook: revenue $125.0 million to $133.0 million; GAAP diluted EPS $0.12 to $0.20
Proto Labs said its chief technology officer, Oleg Ryaboy, will leave the company effective November 2, 2025, and that Marc Kermisch will take over as Chief Technology & AI Officer effective October 13, 2025. Ryaboy will receive severance benefits under the company's standard executive severance agreement, and the filing does not state a dollar amount. The change is a senior executive transition with no financial results or guidance included.
Oleg Ryaboy, Chief Technology Officer, departs effective November 2, 2025 and is no longer an executive officer as of October 3, 2025
Marc Kermisch appointed Chief Technology & AI Officer effective October 13, 2025
Kermisch previously served as CTO at Emergent Software and as Global Chief Digital and Information Officer at Case New Holland
Ryaboy's severance follows Section 5(A) of the executive severance agreement filed June 6, 2022
Proto Labs reported record second-quarter 2025 revenue of $135.1 million, up 7.5% from a year earlier, while GAAP net income was $4.4 million, or $0.18 per diluted share, slightly below the prior-year $4.5 million. Non-GAAP EPS rose to $0.41 from $0.38, and the company guided third-quarter 2025 revenue to $130.0 million to $138.0 million, which matters to shareholders because sales grew while reported profit slipped.
Revenue was $135.1 million, up 7.5% from $125.6 million; Protolabs Network revenue rose 18.6% to $29.3 million.
GAAP net income was $4.4 million, or $0.18 per diluted share, versus $4.5 million, or $0.18, in Q2 2024.
Non-GAAP net income was $10.0 million, or $0.41 per diluted share, versus $0.38 in Q2 2024; excluded CEO transition costs were $1.4 million.
Q3 2025 outlook: revenue of $130.0 million to $138.0 million and GAAP diluted EPS of $0.17 to $0.25.
Proto Labs entered a new consulting agreement with Robert Bodor, who ceased to be President and CEO effective May 20, 2025. Under the agreement dated May 28, 2025, Bodor will provide transitional services for a monthly fee of $5,000 through November 11, 2025, subject to him signing a general waiver and release of claims.
Monthly consulting fee of $5,000, with the term running through November 11, 2025
Agreement is conditioned on Bodor signing and not rescinding a general waiver and release of claims
Bodor keeps vested stock options until the agreement ends or he exercises them; unvested options are forfeited, and vested options may be exercised for three months after termination or expiration
Proto Labs' board appointed Suresh Krishna as President and Chief Executive Officer effective May 20, 2025, succeeding Robert Bodor, who left the CEO role and the board. Krishna also joined the board, and the company reaffirmed its second-quarter 2025 outlook. The leadership change is the main news for shareholders, and the company did not change its prior guidance.
Krishna's employment began May 20, 2025; he was CEO of Northern Tool + Equipment from April 2020 to November 2024.
His employment agreement sets an initial base salary of $800,000 and a target bonus of 100% of base salary.
The company reaffirmed Q2 2025 revenue guidance of $124.0 million to $132.0 million and GAAP diluted EPS of $0.11 to $0.19.
Proto Labs reported first quarter 2025 revenue of $126.2 million, down 1.3% from $127.9 million a year earlier, and GAAP diluted earnings of $0.15 per share versus $0.20. Both revenue and per-share profit declined year over year. The company also gave a second quarter 2025 outlook of $124.0 million to $132.0 million in revenue and GAAP diluted EPS of $0.11 to $0.19.
Revenue was $126.2 million, down 1.3% from $127.9 million; Protolabs Network revenue rose 10.0% to $26.3 million
Net income was $3.6 million, or $0.15 per diluted share, versus $5.3 million, or $0.20, a year earlier; non-GAAP diluted EPS was $0.33 versus $0.40
Repurchased $20.9 million of common stock in the quarter; cash and investments were $116.3 million at March 31, 2025
Q2 2025 outlook: revenue of $124.0 million to $132.0 million; GAAP diluted EPS of $0.11 to $0.19
Proto Labs reported fourth quarter 2024 revenue of $121.8 million, down 2.6% from a year earlier, and a net loss of $0.4 million, or $0.02 per diluted share, compared with net income of $7.0 million a year earlier. Full-year revenue was $500.9 million, down 0.6%, and full-year GAAP earnings were $0.66 per diluted share, flat with 2023. The board also approved a $100 million stock repurchase program.
Q4 2024 revenue was $121.8 million, down 2.6% from $125.0 million in Q4 2023; Q4 net loss was $0.4 million, or $(0.02) per diluted share
Full-year 2024 revenue was $500.9 million, down 0.6%; full-year GAAP net income was $16.6 million, or $0.66 per diluted share, versus $0.66 in 2023
Q1 2025 outlook: revenue between $120 million and $128 million; GAAP diluted EPS between $0.08 and $0.16
New $100 million stock repurchase program approved on February 4, 2025, with no obligation to buy a set amount of shares
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Protolabs filing is on SEC EDGAR ↗. 8-K briefs of other companies →